Breaks Categories: News

ThursdayAug 10, 2017 9:53 am

HempNewsBreaks – Arcadia Biosciences, Inc. (NASDAQ: RKDA) and Bioceres’ Joint Venture Receives Completed Safety Review by FDA

Arcadia Biosciences (NASDAQ: RKDA) before the bell said its joint venture with Bioceres S.A., Verdeca, has received notification that the FDA has completed its full review of the company’s safety evaluation for HB4 soybeans. This permits Verdeca products derived from HB4 soybeans to be used commercially in human food and animal feed. Additionally, completion of the FDA’s review marks a key regulatory achievement in the approval process for Verdeca’s HB4 drought stress tolerance trait. The company has submitted an environmental safety data petition to the U.S. Department of Agriculture (USDA) which is currently under review. The USDA is expected to…

Continue Reading

ThursdayAug 10, 2017 9:49 am

HempNewsBreaks – Data and Safety Monitoring Board Recommends Completion of ARCA biopharma, Inc.’s (NASDAQ: ABIO) GENETIC-AF Trial

ARCA biopharma (NASDAQ: ABIO) this morning said the GENETIC-AF trial Data and Safety Monitoring Board (DSMB) has completed its pre-specified phase 2B interim analysis and has recommended completion of the study with no changes to the trial design. GENETIC-AF is a clinical trial evaluating Gencaro™ as a candidate for the treatment of atrial fibrillation (AF). The Gencaro development program has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA). “The DSMB stated that there were no safety concerns and that the efficacy results met the prespecified criteria for continuing the Phase 2B trial to completion. We…

Continue Reading

ThursdayAug 10, 2017 9:32 am

HempNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) CEO Discusses Company’s Progress in Interview

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced that its chief executive officer, Chris Bunka, was featured in a recent interview on the Uptick Network Stock Day Radio Show. Bunka leveraged the platform to discuss Lexaria’s overall accomplishments in the past three months, as well as the company’s expectations for profitability moving forward. He notes that ongoing research and development programs could open both the NSAID and Nicotine markets to Lexaria, providing an opportunity to significantly increase corporate revenues and facilitate further expansion. “In the…

Continue Reading

TuesdayAug 08, 2017 12:40 pm

HempNewsBreaks – Rennova Health, Inc. (NASDAQ: RNVA) Opens Big South Fork Medical Center

Rennova Health (NASDAQ: RNVA) (NASDAQ: RNVAZ) this morning said it has opened the Big South Fork Medical Center (BSFMC) and provision of 24/7 services. Located in Oneida, Tennessee, the hospital offers in-patient and outpatient services including a 24/7 emergency department. Future plans for the hospital include submitting an application to be classified as a Critical Access Hospital which will in turn enable certain advantages with payers. "We believe our investment and ability to facilitate the needs of doctors and other healthcare providers in the local area will enable us to exceed previous revenues achieved by this hospital. This opening is…

Continue Reading

MondayAug 07, 2017 9:31 am

HempNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Names Keevin Gillespie as Acting President of ChineseHempOil.com Subsidiary

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has appointed Keevin Gillespie as acting president of its wholly-owned ChineseHempOil.com, Inc. subsidiary, effective immediately. Per the update, Gillespie’s initial focus will be on promotion and branding of the company’s newly-launched ‘OptHemp’ health product line, which the company intends to market through several sales channels. He will also be spearheading the development of the company’s network marketing division. “I'm honored to serve as the President of ChineseHempOil.com, Inc.,” Gillespie stated in the news release. “As the many potential health benefits of hemp continue to be revealed through scientific…

Continue Reading

MondayAug 07, 2017 9:05 am

HempNewsBreaks – SinglePoint, Inc. (SING) Provides First-Hand Look at Development of New Bitcoin Exchange

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning offered a first-hand look at its new bitcoin exchange aimed at solving the payments issues plaguing today’s cannabis industry. When completed, the new in-house solution will enable consumers to obtain bitcoin at any point of sale. In addition to bitcoin, SinglePoint is currently in negotiations to make a major purchase from a company that offers a cannabis-specific cryptocurrency to be used specifically within the growing legal cannabis industry, which is on pace to reach $55.8 billion by 2025, per Grand View Research. “We are very excited about this solution,” Wil Ralston,…

Continue Reading

ThursdayAug 03, 2017 12:08 pm

HempNewsBreaks – CHF Solutions, Inc. (NASDAQ: CHFS) Starts Aquadex FlexFlow® System Manufacturing Transition to its Minnesota Facility; Shares Rise

CHF Solutions, Inc. (NASDAQ: CHFS) shares surged 14% after the company this morning said it has commenced the process of transitioning the manufacturing of the Aquadex FlexFlow System from an indirect subsidiary of Baxter International, Inc. (NYSE: BAX) to CHF Solutions’ facility in Eden Prairie, Minnesota. Last week, the company completed the transfer of the manufacturing assets that it acquired from Baxter as part of the Aquadex acquisition that was completed on August 5, 2016. The company expects to begin manufacturing its Aquadex FlexFlow system products in the fourth quarter of 2017. “Bringing the manufacturing of the Aquadex FlexFlow system…

Continue Reading

ThursdayAug 03, 2017 12:05 pm

HempNewsBreaks – Moleculin Biotech, Inc. (NASDAQ: MBRX) Selects Bioscience SA as Polish CRO

Shares of Moleculin Biotech (NASDAQ: MBRX) rose 7% this morning on news that the company has selected Bioscience SA, a Polish contract research organization (CRO), to begin identifying and preparing clinical testing sites in Poland for Annamycin. The company’s drug candidate, Annamycin, is being evaluated for the treatment of relapsed or refractory acute myeloid leukemia (AML). "One of the biggest challenges for most clinical trials is recruiting the right patients on a timely basis. We believe adding Polish sites to our planned trial introduces a significant population of qualified patients, and selecting Bioscience helps ensure we reach those patients effectively…

Continue Reading

ThursdayAug 03, 2017 12:00 pm

HempNewsBreaks – Micronet Enertec Technologies, Inc. (NASDAQ: MICT) Receives Largest Purchase Order Since 2012; Shares Higher

Micronet Enertec Technologies (NASDAQ: MICT) shares surged 34% this morning after the company said its Mobile Resource Management (MRM) subsidiary Micronet Ltd., via its wholly owned subsidiary Micronet Inc., has received purchase orders valued at approximately $4.3 million for its recently released TREQr5 product. The orders for the ruggedized telematics Android on-board computer were received by a fleet management solutions provider that is a current customer. The purchase order marks the largest order received for the company since 2012 and brings the company’s backlog to a record amount of $13.5 million. "The magnitude of these orders, and the fact that…

Continue Reading

ThursdayAug 03, 2017 9:08 am

HempNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Management Quoted in “HIGH TIMES” Article

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the publication of “Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work” on August 1, 2017, by Javier Hasse on the website of “HIGH TIMES,” a publication that’s served as the preeminent source for cannabis information since 1974. In the article, both Ram Mukunda, CEO of IGC, and Dr. Chuanhai Cao, the company’s key advisor, were quoted with respect to the potential therapeutic effects of THC on Alzheimer’s disease, which is noted as America’s most expensive ailment.…

Continue Reading